CDT Equity (CDT) Enterprise Value (2021 - 2026)
CDT Equity's (CDT) quarterly Enterprise Value came in at -$97000.0 in Q1 2026, up 95.45% YoY from -$49630.1 in Q1 2025, and up 93.57% on a QoQ basis from -$1.5 million in Q4 2025.
CDT Equity (CDT) Enterprise Value (2021 - 2026) Analysis & Trends
CDT Equity (CDT) has 6 years of Enterprise Value data on file, last reported at -$97000.0 in Q1 2026.
- Quarterly Enterprise Value rose 95.45% year-over-year to -$97000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$97000.0 (up 95.45% YoY) and the FY2025 annual result came in at -$1.5 million, down 151.5% from the prior year.
- Enterprise Value grew to -$97000.0 in Q1 2026, from -$1.5 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$71000.0 in Q3 2024 to a low of -$8.6 million in Q3 2023.
- A 5-year average of -$1.7 million and a median of -$837687.0 in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value soared 99.18% — and 2025, when it tumbled 5252.11%.
- Tracing CDT's Enterprise Value over 5 years: stood at -$345777.0 in 2022, then sank by 1122.75% to -$4.2 million in 2023, then jumped by 85.81% to -$600000.0 in 2024, then sank by 151.5% to -$1.5 million in 2025, then surged by 93.57% to -$97000.0 in 2026.
- The last three Enterprise Value figures came in at -$97000.0 (Q1 2026), -$1.5 million (Q4 2025), and -$3.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.12 Bn |
| 10 | CDT Equity | 1.55 Mn | 1.55 Mn | - | -747,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -747,000.00 |
| Mar 31, 2026 | -97,000.00 |
| Dec 31, 2025 | -1.51 Mn |
| Sep 30, 2025 | -3.80 Mn |
| Jun 30, 2025 | -3.33 Mn |
| Mar 31, 2025 | -2.13 Mn |
| Dec 31, 2024 | -600,000.00 |
| Sep 30, 2024 | -71,000.00 |
| Jun 30, 2024 | -219,000.00 |
| Mar 31, 2024 | -1.84 Mn |
| Dec 31, 2023 | -4.23 Mn |
| Sep 30, 2023 | -8.64 Mn |
| Jun 30, 2023 | -277,761.00 |
| Mar 31, 2023 | -90,606.00 |
| Dec 31, 2022 | -345,777.00 |
| Sep 30, 2022 | -728,072.00 |
| Jun 30, 2022 | -837,687.00 |
| Mar 31, 2022 | -964,602.00 |
| Dec 31, 2021 | -48,555.00 |